分子生物学
IVD分子诊断
细胞培养与分析
蛋白研究
细胞因子
重组蛋白
抗体
高通量测序建库
病原检测UCF系列
生物医药
工具酶
抑制剂激活剂与常用试剂
仪器
耗材

MiR-485-5p inhibits metastasis and proliferation of osteosarcoma by targeting CX3CL1

F-R Wang, S-H Xu, B-M Wang, F Wang

Journal:European Review for Medical and Pharmacological Sciences

IF:2.39

DOI:10.26355/eurrev_201811_16253

PMID:30468463

Published:2018-11-01

research field:肿瘤学分子生物学遗传学

Abstract

Objective: To investigate the potential effect of miR-485-5p on the development of osteosarcoma (OA) and its relevant mechanism. Patients and methods: The expression level of miR-485-5p was detected in OA tissues and cells (MG-63) comparing with corresponding adjacent normal tissues and normal human osteoblastic cell lines (Hfob1.19), respectively. Luciferase assay was performed to evaluate the interaction between miR-485-5p and CX3CL1, the effects of miR-485-5p on MG-63 cells were determined by subsequent experiments including cell proliferation, expression level of CX3CL1, detection of invasion and migration capacities. Results: In our present research, miR-485-5p was down-regulated in OA tissues and we got the same result in OA cells. In order to obtain potential target of miR-485-5p, we checked it in three publicly available algorithms, TargetScan, miRDB and microRNA. We found that CX3CL1 is a direct target of miR-485-5p, and Luciferase assays confirmed our hypothesis. The results showed that decreased expression of CX3CL1 resulting from the up-regulation of miR-485-5p could decelerate cell proliferation, invasion and migration in OA cells. Conclusions: We showed the suppressor function of miR-485-5p in OA by targeting CX3CL1, indicating that miR-485-5p/CX3CL1 axis might be a potential therapeutic target for the treatment of OA.

本文使用的Yeasen产品

购物车
客服
转染试用